Trial
NCT02829424
Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Assistance Publique Hopitaux De Marseille
Collaborators
—
Condition
Psoriasis
Intervention
Methotrexate
Why stopped
new treatment on the market in direct competition with the new treatment proposed by the study. Recruitment difficulties.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-20